The Technical Analyst
Select Language :
Leap Therapeutics Inc [LPTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Leap Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Leap Therapeutics Inc is listed at the  Exchange

-4.32% $2.66

America/New_York / 28 mar 2024 @ 16:00


Leap Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 68.10 mill
EPS: -3.98
P/E: -0.670
Earnings Date: May 12, 2024
SharesOutstanding: 25.60 mill
Avg Daily Volume: 0.243 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Sell
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.670 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.11x
Company: PE -0.670 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$3.44
(29.41%) $0.782
Date: 2024-03-28
Expected Trading Range (DAY)

$ 2.40 - 2.98

( +/- 10.63%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-01-29 Mashiach Nissim Buy 25 000 Stock Option (Right to Buy)
2024-01-29 Dietz Thomas John Buy 30 000 Stock Option (Right to Buy)
2024-01-29 Schilsky Richard Buy 25 000 Stock Option (Right to Buy)
2024-01-29 Granfield Christine Buy 85 000 Employee Stock Option (Right to Buy)
2024-01-29 Baum Jason Buy 85 000 Employee Stock Option (Right to Buy)
INSIDER POWER
66.64
Last 95 transactions
Buy: 11 050 606 | Sell: 1 768 106

Forecast: 16:00 - $2.66

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $2.66
Forecast 2: 16:00 - $2.66
Forecast 3: 16:00 - $2.66
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.66 (-4.32% )
Volume 0.192 mill
Avg. Vol. 0.243 mill
% of Avg. Vol 79.14 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Leap Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Leap Therapeutics Inc

RSI

Intraday RSI14 chart for Leap Therapeutics Inc

Last 10 Buy & Sell Signals For LPTX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35buy$3.49N/AActive
Profile picture for
            Leap Therapeutics Inc

LPTX

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Last 10 Buy Signals

Date Signal @
XMRUSDMar 28 - 21:45$135.23
POLYXUSDMar 28 - 21:430.546
ATORUSDMar 28 - 21:443.39
KUJIUSDMar 28 - 21:422.70
ETH2X-FLIUSDMar 28 - 21:4131.07
PEPECOINUSDMar 28 - 21:395.27
XVSUSDMar 28 - 21:38$16.08
BAKEUSDMar 28 - 21:38$0.449
CTXUSDMar 28 - 21:384.86
DUSKUSDMar 28 - 21:380.605

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.